List of Excipients in API lodoxamide tromethamine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lodoxamide tromethamine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | ALOMIDE | lodoxamide tromethamine | 0065-0345 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | ALOMIDE | lodoxamide tromethamine | 0065-0345 | CITRIC ACID MONOHYDRATE | |
| Alcon Laboratories Inc | ALOMIDE | lodoxamide tromethamine | 0065-0345 | EDETATE DISODIUM | |
| Alcon Laboratories Inc | ALOMIDE | lodoxamide tromethamine | 0065-0345 | HYDROCHLORIC ACID | |
| Alcon Laboratories Inc | ALOMIDE | lodoxamide tromethamine | 0065-0345 | HYPROMELLOSE 2910 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lodoxamide tromethamine
Excipient focus: BENZALKONIUM CHLORIDE
lodoxamide tromethamine drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CITRIC ACID MONOHYDRATE
lodoxamide tromethamine drug variants containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
lodoxamide tromethamine drug variants containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
lodoxamide tromethamine drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
lodoxamide tromethamine drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
lodoxamide tromethamine drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
lodoxamide tromethamine drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
lodoxamide tromethamine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TYLOXAPOL
lodoxamide tromethamine drug variants containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing TYLOXAPOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
lodoxamide tromethamine drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | lodoxamide tromethamine | 0065-0345 |
| Novartis Pharmaceuticals Corporation | lodoxamide tromethamine | 0078-0736 |
| >Company | >Ingredient | >NDC |
lodoxamide tromethamine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch